ELEVEN BIOTHERAPEUTICS, INC.
Profile
Company Names
ELEVEN BIOTHERAPEUTICS, INC.
Addresses
245 FIRST STREET, SUITE 1800, CAMBRIDGE, MA 02142
215 FIRST STREET, SUITE 400, CAMBRIDGE, MA 02142
790 MEMORIAL DRIVE, CAMBRIDGE, MA 02139
Phone Numbers
617-444-8550
617-494-0768
617-871-9911
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2008
State Incorporated:
DELAWARE
Total Amount Raised:
$43,271,288.00
Number of Funding Rounds:
4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2018-03-21
$996,016.00
$996,016.00
$0.00
Equity
3
2016-09-20
$13,525,262.00
$13,525,262.00
$0.00
Equity
2
2014-12-02
$20,000,010.00
$20,000,010.00
$0.00
Equity
1
2010-02-09
$8,750,000.00
$35,000,000.00
$26,250,000.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
PAUL
CHANEY
DIRECTOR
KIM
C.
DRAPKIN
EXECUTIVE OFFICER
MARK
LEVIN
EXECUTIVE OFFICER, DIRECTOR
NINEPOINT MEDICAL, INC.
| ELEVEN BIOTHERAPEUTICS, INC.
| CONSTELLATION PHARMACEUTICALS INC
| FOUNDATION MEDICINE, INC.
| KARSAMERICA FINANCE LLC
| DC DEVICES, INC.
| THIRD ROCK VENTURES III, L.P.
| ALLSTAR DEALS, INC.
| MAKI SHOP STORE 1 LLC
| ROLL-D HOLDINGS, LLC
| VOYAGER THERAPEUTICS, INC.
| CORVIA MEDICAL, INC.
| FULCRUM THERAPEUTICS, INC.
| MAKI SHOP STORE 3 LLC
| HIRSHMARK CAPITAL REIT LLC
DANIEL
S.
LYNCH
DIRECTOR
JOHN
MCCABE
EXECUTIVE OFFICER
GREGORY
D.
PERRY
EXECUTIVE OFFICER
CARY
PFEFFER
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2018-03-21
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2016-09-20
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2014-12-02
